A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications | MicrobiomeTrials
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2019-12-04Est. Completion: 2022-06-17
Enrollment target: 71 participants
Locations
Site 143, Bentonville, Arkansas, United States
Site 249, Little Rock, Arkansas, United States
Site 153, Culver City, California, United States
Site 239, Garden Grove, California, United States
Site 134, Lemon Grove, California, United States
Site 126, Oakland, California, United States
Site 163, Oceanside, California, United States
Site 229, Rancho Cucamonga, California, United States
Site 202, Miami, Florida, United States
Site 144, North Miami, Florida, United States
Site 241, Okeechobee, Florida, United States
Site 140, Chicago, Illinois, United States
Site 140, Lincolnwood, Illinois, United States
Site 146, Wichita, Kansas, United States
Site 138, Glen Burnie, Maryland, United States
Site 151, Las Vegas, Nevada, United States
Site 216, New York, New York, United States
Site 181, Raleigh, North Carolina, United States
Site 181, Raleigh, North Carolina, United States
Other microbiome trials you might be interested in